A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance

Clinical trial NCT03114865 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03114865
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia B-cell Non Hodgkin Lymphoma Pre B-Cell Acute Lymphoblastic Leukaemia

Start date: 2017-09-05
Primary completion: 2026-10-30
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.